Related Experiment Videos
Abstract:
1. The clinical manifestations, laboratory data and renal histologic features of acute renal failure occurring in 14 patients with multiple myeloma are reviewed and contrasted with the data from 29 previously reported cases. 2. Whereas other reports have stressed the role of intravenous pyelography and dehydration in the development of acute renal failure in multiple myeloma, the most common etiologic factor in our experience was hypercalcemia (7 patients). Other factors included potentially nephrotoxic antibiotics (3 patients) and volume depletion (2 patients). Intravenous pyelography could be clearly implicated in ony one patient. 3. The unusually high incidence of Bence Jones proteinuria in these patients is consistent with the possibility that Bence Jones protein excretion is associated with an increased susceptibility to renal injury. This could be due to an adverse effect of Bence Jones proteins on the renal tubules or their tendency to precipitate in tubular lumina during periods of reduced tubular flow. 4. The prognosis of patients with multiple myeloma who develop acute renal failure is poor; only 5 of our 14 patients survived the early period of acutely impaired renal function, and 4 of these subsequently died within 2 months. Preventive measures particularly the prompt correction of hypercalcemia and volume depletion, are the most important aspects of patient management.
Insights
Hypercalcemia is a primary cause of acute kidney injury in multiple myeloma patients, unlike previous reports focusing on IVP. Prompt management of hypercalcemia and volume depletion is crucial for poor prognosis in these patients.
Area of Science:
- Nephrology
- Oncology
- Internal Medicine
Background:
- Multiple myeloma is a plasma cell malignancy.
- Acute kidney injury (AKI) is a serious complication in multiple myeloma.
- Previous studies identified intravenous pyelography and dehydration as key AKI factors.
Purpose of the Study:
- To review clinical, laboratory, and histologic features of AKI in multiple myeloma.
- To identify the primary etiologic factors of AKI in a new cohort.
- To contrast findings with previously reported cases.
Main Methods:
- Retrospective review of 14 multiple myeloma patients with AKI.
- Analysis of clinical manifestations, laboratory data, and renal histology.
- Comparison with 29 previously reported cases.
Main Results:
- Hypercalcemia was the most common cause of AKI (7/14 patients).
- Nephrotoxic antibiotics (3/14) and volume depletion (2/14) were other factors.
- Bence Jones proteinuria may increase susceptibility to renal injury.
- Intravenous pyelography implicated in only one patient.
Conclusions:
- Hypercalcemia is a critical, often overlooked, cause of AKI in multiple myeloma.
- Bence Jones protein may contribute to renal tubule damage.
- The prognosis for multiple myeloma patients with AKI is poor.
- Preventive strategies focusing on hypercalcemia and volume status are essential.